Zhang et al. found that AS-IV (10 and 50 mg/kg/d) has a relaxing effect on the pulmonary artery of PAH model rats and reduces the serum levels of ET-1, Ang II, TNF-α, and IL-6 in PAH model rats. This evidence concerns the gene EDN1 and pulmonary arterial hypertension.